Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-08-12 00:00:00 ET · period of report 2025-08-09 · accession 0000950170-25-107555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-12 | 2025-08-09 | TMCI | Scanlan Sean F. | Chief Innovation Off | F - Tax | $0.00 | -9,814 | 373.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-09 | F | D | 9,814 | $0.00 | 373,807 | D | — | — | (F1) Includes 284,798 restricted stock units. |